Product Code: ETC4471765 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
Sepsis is a life-threatening condition, and accurate and timely diagnosis is critical for patient survival. The India Sepsis Diagnostics market has evolved to meet this need. Various diagnostic methods, including blood culture, molecular diagnostics, and biomarker assays, are used to identify sepsis. The market has been driven by the growing incidence of sepsis in healthcare facilities, along with efforts to enhance early detection through technological advancements. Rapid diagnostic tests and automated systems have gained prominence, reducing the time required for diagnosis and increasing treatment efficacy. The market is expected to continue to grow as healthcare facilities prioritize sepsis management and invest in cutting-edge diagnostic solutions.
The sepsis diagnostics market is driven by the need for early detection and rapid treatment of sepsis, a life-threatening condition. Advances in sepsis diagnostic methods, increased awareness of sepsis among healthcare professionals, and government initiatives for infectious disease control are key drivers. Rapid and accurate sepsis diagnostics are critical in improving patient outcomes, further fueling market growth.
Challenges in the India sepsis diagnostics market include the need for rapid and accurate diagnostics, accessibility, and awareness. Sepsis is a life-threatening condition, and early diagnosis is crucial. Ensuring that rapid and reliable sepsis diagnostic tools are available in healthcare facilities across the country is a challenge. Many individuals and healthcare providers may not be fully aware of the symptoms and importance of early sepsis detection.
The sepsis diagnostics market gained importance in COVID-19 care, as sepsis is a common complication in critically ill COVID-19 patients. Hospitals focused on improving sepsis detection and management, impacting the market positively.
Major players in the India Sepsis Diagnostics market include Becton, Dickinson and Company, bioM?rieux SA, Danaher Corporation, Roche Diagnostics, and Thermo Fisher Scientific.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Sepsis Diagnostics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Sepsis Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 India Sepsis Diagnostics Market - Industry Life Cycle |
3.4 India Sepsis Diagnostics Market - Porter's Five Forces |
3.5 India Sepsis Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 India Sepsis Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 India Sepsis Diagnostics Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 India Sepsis Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.9 India Sepsis Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 India Sepsis Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Sepsis Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of sepsis cases in India |
4.2.2 Growing awareness about the importance of early sepsis diagnosis and treatment |
4.2.3 Technological advancements in sepsis diagnostic tools and techniques |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure in certain regions of India |
4.3.2 High cost associated with sepsis diagnostic tests and treatments |
4.3.3 Lack of trained healthcare professionals for accurate sepsis diagnosis |
5 India Sepsis Diagnostics Market Trends |
6 India Sepsis Diagnostics Market, By Types |
6.1 India Sepsis Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 India Sepsis Diagnostics Market Revenues & Volume, By Technology, 2021-2031F |
6.1.3 India Sepsis Diagnostics Market Revenues & Volume, By Blood Culture, 2021-2031F |
6.1.4 India Sepsis Diagnostics Market Revenues & Volume, By Immunoassays, 2021-2031F |
6.1.5 India Sepsis Diagnostics Market Revenues & Volume, By Molecular Diagnostics, 2021-2031F |
6.1.6 India Sepsis Diagnostics Market Revenues & Volume, By Flow Cytometry, 2021-2031F |
6.1.7 India Sepsis Diagnostics Market Revenues & Volume, By Microfluidics, 2021-2031F |
6.1.8 India Sepsis Diagnostics Market Revenues & Volume, By Biomarkers, 2021-2031F |
6.2 India Sepsis Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 India Sepsis Diagnostics Market Revenues & Volume, By Blood Culture Media, 2021-2031F |
6.2.3 India Sepsis Diagnostics Market Revenues & Volume, By Assays & Reagents, 2021-2031F |
6.2.4 India Sepsis Diagnostics Market Revenues & Volume, By Instruments, 2021-2031F |
6.2.5 India Sepsis Diagnostics Market Revenues & Volume, By Software, 2021-2031F |
6.3 India Sepsis Diagnostics Market, By Method |
6.3.1 Overview and Analysis |
6.3.2 India Sepsis Diagnostics Market Revenues & Volume, By Automated Diagnostics, 2021-2031F |
6.3.3 India Sepsis Diagnostics Market Revenues & Volume, By Conventional Diagnostics, 2021-2031F |
6.4 India Sepsis Diagnostics Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 India Sepsis Diagnostics Market Revenues & Volume, By Bacterial Sepsis, 2021-2031F |
6.4.3 India Sepsis Diagnostics Market Revenues & Volume, By Fungal Sepsis, 2021-2031F |
6.4.4 India Sepsis Diagnostics Market Revenues & Volume, By Viral Sepsis, 2021-2031F |
6.4.5 India Sepsis Diagnostics Market Revenues & Volume, By Other Pathogen, 2021-2031F |
6.5 India Sepsis Diagnostics Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 India Sepsis Diagnostics Market Revenues & Volume, By Laboratory Tests, 2021-2031F |
6.5.3 India Sepsis Diagnostics Market Revenues & Volume, By Point-of-Care Tests, 2021-2031F |
6.6 India Sepsis Diagnostics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 India Sepsis Diagnostics Market Revenues & Volume, By Hospitals and specialty clinics, 2021-2031F |
6.6.3 India Sepsis Diagnostics Market Revenues & Volume, By Pathology & Reference Laboratories, 2021-2031F |
6.6.4 India Sepsis Diagnostics Market Revenues & Volume, By Research Laboratories & Academic Institutes, 2021-2031F |
7 India Sepsis Diagnostics Market Import-Export Trade Statistics |
7.1 India Sepsis Diagnostics Market Export to Major Countries |
7.2 India Sepsis Diagnostics Market Imports from Major Countries |
8 India Sepsis Diagnostics Market Key Performance Indicators |
8.1 Average time taken for sepsis diagnosis |
8.2 Percentage of hospitals equipped with advanced sepsis diagnostic tools |
8.3 Number of sepsis awareness campaigns conducted annually |
9 India Sepsis Diagnostics Market - Opportunity Assessment |
9.1 India Sepsis Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 India Sepsis Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 India Sepsis Diagnostics Market Opportunity Assessment, By Method, 2021 & 2031F |
9.4 India Sepsis Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.5 India Sepsis Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 India Sepsis Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Sepsis Diagnostics Market - Competitive Landscape |
10.1 India Sepsis Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 India Sepsis Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |